Entrepreneur on a Mission to Cure Ultra-Rare Diseases
Manisha Kaura is not just the founder of Kaura Therapeutics but a woman on a mission – a mission to tackle ultra-rare diseases head-on. Her nonprofit organization, Kaura Therapeutics, is devoted to addressing disparities in treatments for conditions like Trimethylaminuria and Isovaleric Acidemia through groundbreaking gene therapies and enzyme replacement therapies.
Born with a rare disease that manifested at age 11, Manisha has experienced firsthand the challenges and stigma that come with such conditions. Motivated by her own struggles, she aims to not only find a cure for her own disease but also for related conditions that affect countless others. With a background in the nonprofit sector and linguistics, Manisha brings a unique perspective to the table, ensuring that donor contributions are utilized efficiently and partnerships are forged strategically.
In the next five years, Manisha envisions Kaura Therapeutics making significant strides in the medical field. By conducting joint Phase 1 and Phase 2 clinical trials for both Trimethylaminuria and Isovaleric Acidemia therapies, the organization is paving the way for groundbreaking treatments. With nearly 7,000 rare diseases plaguing the world, Manisha’s goal is clear – to eliminate the burden of ultra-rare diseases through innovative solutions and ample fundraising efforts.
Success, according to Manisha, is not just about overcoming obstacles but about doing so efficiently. She believes that transformation occurs through consistent, measurable actions taken daily. Currently transitioning from public assistance to building a nonprofit organization from the ground up, Manisha is determined to achieve success in her endeavors.
Exciting news surrounds Kaura Therapeutics as the organization has recently filed incorporation paperwork to become a registered nonprofit in New York State. Additionally, they are in the process of securing 501-c(3) registration, a significant milestone in their journey towards fulfilling their mission.
As Kaura Therapeutics embarks on this noble quest to eradicate ultra-rare diseases, Manisha invites donors interested in making a tangible difference to join her cause. With ambitious clinical trials on the horizon and a commitment to pioneering treatments for these debilitating conditions, Kaura Therapeutics is poised to make a lasting impact on the landscape of rare disease research and treatment.
To learn more about Kaura Therapeutics and how you can support their mission, visit their website at www.kauratherapeutics.org or connect with Manisha Kaura on LinkedIn at www.linkedin.com/in/manishakaura.